Annexon (ANNX) Revenue & Revenue Breakdown
Annexon Revenue Highlights
Annexon Revenue by Period
Annexon Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Annexon Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $4.87M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
Annexon Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
BPMC | Blueprint Medicines | $249.38M | $138.16M |
RCUS | Arcus Biosciences | $117.00M | $39.00M |
WVE | Wave Life Sciences | $113.31M | $19.69M |
VECT | VectivBio | $27.34M | $676.00K |
RLAY | Relay Therapeutics | $25.55M | - |
KRTX | Karuna Therapeutics | $654.00K | - |
CGEM | Cullinan Oncology | - | - |
GPCR | Structure Therapeutics | - | - |
XFOR | X4 Pharmaceuticals | - | $563.00K |
AVRO | AVROBIO | - | - |
CNSP | CNS Pharmaceuticals | - | - |
DAWN | Day One Biopharmaceuticals | - | $8.19M |
ZURA | Zura Bio | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
INAB | IN8bio | - | - |
ANNX | Annexon | - | - |
IMMX | Immix Biopharma | - | - |
HEPA | Hepion Pharmaceuticals | - | - |
ANNX Revenue FAQ
What is Annexon’s yearly revenue?
Annexon's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ANNX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Annexon’s quarterly revenue?
Annexon's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ANNX's quarterly revenue for Q4 2023 was $4.87M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Annexon’s revenue growth rate?
Annexon's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.